Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Ridderström

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|October 6, 2007
CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolitesMarie M Ahlström, Marianne Ridderström, Ismael Zamora
Journal of Chemical Information and Modeling|September 27, 2005
Virtual screening and scaffold hopping based on GRID molecular interaction fieldsMarie M Ahlström, Marianne Ridderström, Kristina Luthman, et al.
Journal of Medicinal Chemistry|August 19, 2007
CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitorsMarie M Ahlström, Marianne Ridderström, Ismael Zamora, et al.
Biochemical Pharmacology|October 24, 2002
The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populationsTashinga E Bapiro, Julia A Hasler, Marianne Ridderström, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrateXue-Qing Li, Anders Björkman, Tommy B Andersson, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|October 6, 2007
CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolitesMarie M Ahlström, Marianne Ridderström, Ismael Zamora
Journal of Chemical Information and Modeling|September 27, 2005
Virtual screening and scaffold hopping based on GRID molecular interaction fieldsMarie M Ahlström, Marianne Ridderström, Kristina Luthman, et al.
Journal of Medicinal Chemistry|August 19, 2007
CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitorsMarie M Ahlström, Marianne Ridderström, Ismael Zamora, et al.
Biochemical Pharmacology|October 24, 2002
The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populationsTashinga E Bapiro, Julia A Hasler, Marianne Ridderström, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrateXue-Qing Li, Anders Björkman, Tommy B Andersson, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 1